Nature Communications (Jan 2018)

Engineering yeast for the production of breviscapine by genomic analysis and synthetic biology approaches

  • Xiaonan Liu,
  • Jian Cheng,
  • Guanghui Zhang,
  • Wentao Ding,
  • Lijin Duan,
  • Jing Yang,
  • Ling Kui,
  • Xiaozhi Cheng,
  • Jiangxing Ruan,
  • Wei Fan,
  • Junwen Chen,
  • Guangqiang Long,
  • Yan Zhao,
  • Jing Cai,
  • Wen Wang,
  • Yanhe Ma,
  • Yang Dong,
  • Shengchao Yang,
  • Huifeng Jiang

DOI
https://doi.org/10.1038/s41467-018-02883-z
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 10

Abstract

Read online

Breviscapine is the flavonoid extract from medical plant Erigeron breviscapus for the treatment of cardio- and cerebrovascular disease. Here, the authors identify the key enzymes of the biosynthetic pathway from the plant genome and engineer yeast to produce breviscapine from glucose.